AD
Aflibercept(CAS: 845771-78-0)
CAS Number
Related Products
Infliximab
CAS Number: 170277-31-3
GLP-1 moiety from Dulaglutide
CAS Number: 923950-08-7
Eculizumab
CAS Number: 219685-50-4
Atezolizumab
CAS Number: 1380723-44-3
Daratumumab
CAS Number: 945721-28-8
![2-Amino-9-{(1S,3R,4S)-4-(benzyloxy)-3-[(benzyloxy)methyl]-2-methylenecyclopentyl}-1,9-dihydro-6H-purin-6-one](https://static.chemtradehub.com/structs/142/142217-81-0-cd33.webp)
Ustekinumab
CAS Number: 815610-63-0
Telavancin HCl
CAS Number: 560130-42-9
Other Suppliers for Aflibercept
Basic Information
Molecular Weight
0 g/mol
Chemical Identifiers
SMILES
BrC1=C(C([H])([H])[H])C2=C(SC(=C2C([H])([H])[H])Br)S1
InChIKey
CAKZHCORWHLXLQ-UHFFFAOYSA-N
FAQ
Aflibercept (CAS: 845771-78-0) is a recombinant fusion protein that binds vascular endothelial growth factor (VEGF) and placental growth factor (PlGF), used in the treatment of age-related macular degeneration, diabetic macular edema, and neovascular glaucoma.
Aflibercept (CAS: 845771-78-0) is primarily used in ophthalmology to treat conditions such as age-related macular degeneration, diabetic macular edema, and neovascular glaucoma. It is administered through intravitreal injection.
Aflibercept (CAS: 845771-78-0) is generally considered safe when used under medical supervision. However, it may cause side effects such as cataracts, increased eye pressure, and retinal detachment. Proper patient monitoring and follow-up are essential to ensure safety.
Aflibercept (CAS: 845771-78-0) should be stored refrigerated at 2°C to 8°C (36°F to 46°F) in its original packaging. It should be protected from light and should not be frozen. The container should be kept tightly closed to maintain its stability and efficacy.
Safety Notice
Please verify product specifications and safety data before use. Contact the supplier for detailed safety information.
Always follow proper handling procedures
Contact Information
Contact Person
Gu Guiping
756037401@qq.com